X
Please Wait
Applying Filters...
01 DOCETAXEL (4)
02 docetaxel trihydrate (3)
01 AqVida GmbH (2)
02 Eriochem S.A. (1)
03 SANOFI AVENTIS US (4)
01 INJECTABLE;INJECTION (4)
02 INJECTION CONCENTRATE (1)
03 SOLUTION FOR INFUSION (2)
01 160MG/8ML (20MG/ML) (1)
02 20MG (1)
03 20MG/ML (1)
04 20MG/ML (20MG/ML) (1)
05 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
06 80MG/4ML (1)
07 80MG/4ML (20MG/ML) (1)
01 Argentina (1)
02 Germany (2)
03 USA (4)
ICRI Spring Convention
Not Confirmed
Contact SupplierICRI Spring Convention
Not Confirmed
Contact SupplierICRI Spring Convention
Not Confirmed
Contact SupplierICRI Spring Convention
Not Confirmed
Contact Supplier
19
Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is DOCETAXEL, with a corresponding application number 20449 and regulatory information .
proudly manufactured in the
approval since 2010-08-03
Sanofi's TAXOTERE INJECTABLE;INJECTION, medication with 20MG/ML (20MG/ML) of DOCETAXEL.
18
Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is DOCETAXEL, with a corresponding application number 20449 and regulatory information .
proudly manufactured in the
approval since 2010-08-02
Sanofi's TAXOTERE INJECTABLE;INJECTION, medication with 80MG/4ML (20MG/ML) of DOCETAXEL.
17
Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is DOCETAXEL, with a corresponding application number 20449 and regulatory information .
proudly manufactured in the
approval since 1996-05-14
Sanofi's TAXOTERE INJECTABLE;INJECTION, medication with 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of DOCETAXEL.
16
Sanofi, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their notable products is DOCETAXEL, with a corresponding application number 20449 and regulatory information .
proudly manufactured in the
approval since 2012-04-13
Sanofi's TAXOTERE INJECTABLE;INJECTION, medication with 160MG/8ML (20MG/ML) of DOCETAXEL.
15
AqVida GmbH, based in Germany, is a pharmaceutical company.
One of their notable products is docetaxel trihydrate, with a corresponding application number 20449 and regulatory information .
proudly manufactured in the
AqVida GmbH's SOLUTION FOR INFUSION, medication with 20MG/ML of docetaxel trihydrate.
14
AqVida GmbH, based in Germany, is a pharmaceutical company.
One of their notable products is docetaxel trihydrate, with a corresponding application number 20449 and regulatory information .
proudly manufactured in the
AqVida GmbH's SOLUTION FOR INFUSION, medication with 80MG/4ML of docetaxel trihydrate.
13
Eriochem S.A., based in Argentina, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is docetaxel trihydrate, with a corresponding application number 20449 and regulatory information .
proudly manufactured in the
Eriochem S.A.'s ERIOX INJECTION CONCENTRATE, medication with 20MG of docetaxel trihydrate.
Market Place
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
